The present invention relates to polymorphic forms of the compound of FormulaI (i.e.,ethyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate (CDDO ethyl ester)) andmethods of usingthem for treating a variety of disease states such as cancer and condisitonsassociated withinflammation.(see formula I)